CENTER FOR DISEASE ANALYSIS FOUNDATION INC (EIN 810946224) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

HOMAUNE RAZAVI

Phone

7208904848

Tax Period

2024-01-01 to 2024-12-31

CENTER FOR DISEASE ANALYSIS FOUNDATION INC, founded in 2013, is a community nonprofit in the Medical Research sector that reported $8.6M in total revenue in fiscal year 2024. Revenue surged 873% from the prior year, signaling strong growth momentum. The organization ran a surplus of $5.6M, a strong 65% operating margin.

Mission

TO ELIMINATE WORLDWIDE SUFFERING, ADVERSE SOCIETAL IMPACT, AND MORTALITY CAUSED BY PREVENTABLE, TREATABLE DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $6,258,096

Program Service Revenue $2,031,051

Investment Income $309,498

Other Revenue $12,445

TOTAL REVENUE $8,611,090

Expense Breakdown

Grants Paid $1,525,050

Salaries & Benefits $775,560

Fundraising Expenses $15,913

Program Expenses $2,702,468

Other Expenses $672,726

TOTAL EXPENSES $2,973,336

Year-over-Year Comparison

	2024	2023	Change
Revenue	$8,611,090	$884,663	+8.7%
Expenses	$2,973,336	$1,377,255	+1.2%
Net Income	$5,637,754	$-492,592	-12.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$70,595

Total Directors

$70,595

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HOMAUNE RAZAVI	PRESIDENT	40.00	Officer Director	$30,000	$40,595	$70,595
ARMIN RAHIMI	SECRETARY	1.00	Officer Director	$0	$0	$0
DOUG SPURGIN	TREASURER	1.00	Officer Director	$0	$0	$0
CHRISTINE SHEARER	MEMBER	1.00	Director	$0	$0	$0
LILLIAN LU	MEMBER	1.00	Director	$0	$0	$0
LISA BRIGHT	MEMBER	1.00	Director	$0	$0	$0
DEVIN RAZAVI-SHEARER	EMPLOYEE	40.00	Highest	$126,981	$25,633	$152,614

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$8,611,090	$2,973,336	$15,135,624	$5,637,754
2023	$884,663	$1,377,255	$6,956,273	$-492,592
2022	$1,269,048	$1,323,638	$3,671,451	$-54,590
2021	$2,026,951	$1,461,181	$3,700,943	$565,770
2020	$2,146,382	$1,881,624	$3,567,940	$264,758
2020	$2,054,370	$1,702,345	$3,479,304	$352,025
2019	$4,945,600	$2,453,315	$3,482,451	$2,492,285
2018	$1,653,737	$1,934,638	$470,798	$-280,901

CENTER FOR DISEASE ANALYSIS FOUNDATION INC